VERVE-102: The Gene Editing Marvel for Heart Health

Ladies and gents, meet VERVE-102, the gene-editing wizardry that’s here to send bad cholesterol packing! In a dazzling display of science, this one-time infusion is turning hearts into fortresses by zapping the pesky PCSK9 gene. Early trials? A jaw-dropping 62% reduction in LDL levels! Who needs lifelong meds when you can have a superhero serum for your arteries? Talk about a game changer!

Quick rundown

1.VERVE-102 shows promise in lowering bad cholesterol permanently.

2.Base editing targets PCSK9 gene to reduce LDL levels.

3.Phase 1 trial shows significant cholesterol reduction.

4.Some participants had mild infusion reactions.

5.Future trials could revolutionize heart disease prevention.

China's GLP-1 Pills: The Game-Changer for India's Obesity Market
China's GLP-1 Pills: The Game-Changer for India's Obesity Market
Hold onto your lab coats, folks! China’s weight-loss pills are crashing the Indian pharma party, and they’re bringing the glitz! With Innovent and Hengrui leading the charge, these GLP-1 marvels offer a no-needle approach to shedding pounds. Forget the old-school injections; it’s all about popping a pill and saying goodbye to those extra snacks. Obesity, meet your match!
11:40 am on Monday, 27 April, 2026

Series

View All

Cricket